Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone

• Zhou Hong,
• Li Xiao-Feng,
• Chen Mu-Jin,
• Cai Li-Li

Affiliations

Zhou Hong

Departmentof Pharmacy, Fujian Maternity and Child Health Hospital, Fujian, Fuzhou, China

Li Xiao-Feng

Departmentof Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Fujian, Quanzhou, China

Chen Mu-Jin

Departmentof Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Fujian, Quanzhou, China

Cai Li-Li

Departmentof Pharmacy, First Hospital of Quanzhou Affiliated to Fujian Medical University, Fujian, Quanzhou, China